Charles Gorman Kevin, Director: Neurocrine Biosciences NBIX Planned sale · Filed 25/02/13

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Charles Gorman KevinDirector
Planned sale date: 25/02/13
Filed: 25/02/13

More to sell after $22.5M in 3 months

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/01/14~25/03/15

Charles Gorman Kevin's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07

Charles Gorman Kevin, Director — plans to sell 3,012 sh of Neurocrine Biosciences NBIX · $352.9K · around 02/13 · 10b5-1 plan | Whalegun